<DOC>
	<DOC>NCT01288885</DOC>
	<brief_summary>This study determined the safety, tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of ASP1941 after a single oral dose (Part A). In addition, it was investigated whether the intake of food had an effect on the PK of ASP1941 (Part B).</brief_summary>
	<brief_title>First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects</brief_title>
	<detailed_description>This study consists of two parts. Part A is a double-blind, placebo controlled single dose escalation study to evaluate the safety and tolerability of single ascending doses of ASP1941. Part B is an open label, crossover design food-effect study to evaluate the effect of fed conditions on the PK of ASP1941.</detailed_description>
	<criteria>Body weight between 60100 kg, body mass index (BMI) between 2030 kg/m2, inclusive Fasting Plasma Glucose (FPG) &gt; 6.4 mmol/l HbA1c &gt; 6.2% Pulse &lt;40 or &gt;90 beats per minute; Systolic Blood Pressure (SBP) &lt;90 or &gt;140 mmHg; Diastolic Blood Pressure (DBP) &lt;40 or &gt;95mmHg</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>First in Men</keyword>
</DOC>